GlaxoSmithKline PLC is urging the Food and Drug Administration to take dissolvable smokeless tobacco products off the market.
Read this article:
Glaxo urges FDA to withdraw dissolvable tobacco
Popular Posts:
- AMCP Review of Health Care Reform Legislation (Part 1)
- Anadys hepatitis C drug meets key study goals
- Summary Box: Lilly halts Alzheimer’s drug
- Medicare Prescription Drug Coverage For Dummies
- Bristol-Myers reports diabetes drug results